Gladius Capital Management LP - REGENERON PHARMACEUTICALS ownership

REGENERON PHARMACEUTICALS's ticker is and the CUSIP is 75886F957. A total of 10 filers reported holding REGENERON PHARMACEUTICALS in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Gladius Capital Management LP ownership history of REGENERON PHARMACEUTICALS
ValueSharesWeighting
Q2 2023$21,556,200
-56.3%
30,000
-50.0%
1.05%
-63.3%
Q1 2023$49,300,20060,0002.87%
Other shareholders
REGENERON PHARMACEUTICALS shareholders Q3 2023
NameSharesValueWeighting ↓
IMC-Chicago, LLC 73,100$35,315,0000.04%
GROUP ONE TRADING, L.P. 46,700$22,561,0000.04%
SIMPLEX TRADING, LLC 365$17,633,0000.02%
SG Americas Securities, LLC 19,200$2,212,0000.01%
JPMORGAN CHASE & CO 22,500$10,870,0000.00%
CONCOURSE FINANCIAL GROUP SECURITIES, INC. 0$00.00%
View complete list of REGENERON PHARMACEUTICALS shareholders